Business

Newron Announces AGM 2026 Results

MILAN, ITALY - April 23, 2026 (NEWMEDIAWIRE) - Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ner...

Newron Pharmaceuticals S.p.a.April 23, 20262
Newron Announces AGM 2026 Results

About this update from Newron Pharmaceuticals S.p.a.

View the original release on www.newmediawire.com

View stock analysis, news, and events for Newron Pharmaceuticals S.p.a.

Newron Pharmaceuticalsperipheral nervous systembiopharmaceutical companyNP5novel therapiesChris MartinGeorge GaribaldiPaolo Zocchidevelopment programXETRA

More from Newron Pharmaceuticals S.p.a.

All Newron Pharmaceuticals S.p.a. news →